Old drugs for more bugs

This is a 3-year PhD studentship funded by the Cystic Fibrosis Trust focusing on repurposing the multiple sclerosis drug, Glatiramer acetate, to potentiate the action of antibiotics for cystic fibrosis airway infections. The program is offered by Imperial College London and provides comprehensive funding including tuition fees and a stipend. Applications are invited from candidates with a Masters degree (Merit and above) in Microbiology, Biomedical Sciences, or a related discipline. The studentship will be funded for 3 years with a tax-free bursary starting at £22,278 in year 1, to be incremented each year, and tuition fees at the Home rate will also be paid. The start date is Spring 2024, with some flexibility if needed.